Annual savings from FDA generic drug approvals have reached $445 billion in 2023, with year-to-year variations driven by patent expirations of blockbuster drugs. This breakdown shows how generic competition cuts drug costs across the U.S. healthcare system.
Read More
How to Document Safety Alerts on Your Medication List: A Practical Guide for Healthcare Teams
How Amiodarone Impacts Cardiac Resynchronization Therapy (CRT)
Tramadol and Serotonin Syndrome: Why This Opioid Is Different
Medications with a Narrow Therapeutic Index and Expiration Risk
Ascorbic Acid Benefits: The Power of Vitamin C for Health and Wellness
